Mitchell Mcleod Pugh & Williams Inc. boosted its stake in CVS Health Corporation (NYSE:CVS) by 0.0% during the second quarter, Holdings Channel reports. The fund owned 6,283 shares of the pharmacy operator’s stock after buying an additional 1 shares during the period. Mitchell Mcleod Pugh & Williams Inc.’s holdings in CVS Health Corporation were worth $505,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of the company. Keel Point LLC raised its stake in shares of CVS Health Corporation by 0.7% in the first quarter. Keel Point LLC now owns 3,296 shares of the pharmacy operator’s stock valued at $259,000 after buying an additional 22 shares during the last quarter. First City Capital Management Inc. raised its stake in shares of CVS Health Corporation by 0.3% in the first quarter. First City Capital Management Inc. now owns 12,771 shares of the pharmacy operator’s stock valued at $1,003,000 after buying an additional 40 shares during the last quarter. Alpha Windward LLC raised its stake in shares of CVS Health Corporation by 1.5% in the first quarter. Alpha Windward LLC now owns 3,302 shares of the pharmacy operator’s stock valued at $259,000 after buying an additional 49 shares during the last quarter. Norway Savings Bank raised its stake in shares of CVS Health Corporation by 0.3% in the second quarter. Norway Savings Bank now owns 17,014 shares of the pharmacy operator’s stock valued at $1,368,000 after buying an additional 50 shares during the last quarter. Finally, Sheets Smith Wealth Management raised its stake in shares of CVS Health Corporation by 0.6% in the second quarter. Sheets Smith Wealth Management now owns 9,171 shares of the pharmacy operator’s stock valued at $738,000 after buying an additional 55 shares during the last quarter. 81.92% of the stock is owned by institutional investors.

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.34% during trading on Friday, hitting $79.41. The stock had a trading volume of 2,985,502 shares. CVS Health Corporation has a 12-month low of $69.30 and a 12-month high of $98.44. The firm has a market cap of $80.73 billion, a P/E ratio of 15.82 and a beta of 0.91. The firm has a 50 day moving average price of $78.83 and a 200 day moving average price of $78.96.

CVS Health Corporation (NYSE:CVS) last posted its earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Zacks’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The firm had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. During the same period last year, the firm earned $1.32 EPS. The company’s quarterly revenue was up 4.5% on a year-over-year basis. On average, equities analysts expect that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 3rd. Stockholders of record on Monday, July 24th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date of this dividend was Thursday, July 20th. CVS Health Corporation’s dividend payout ratio (DPR) is presently 39.92%.

TRADEMARK VIOLATION NOTICE: “CVS Health Corporation (NYSE:CVS) Shares Bought by Mitchell Mcleod Pugh & Williams Inc.” was originally reported by Daily Political and is the property of of Daily Political. If you are accessing this news story on another domain, it was copied illegally and republished in violation of United States & international copyright legislation. The original version of this news story can be viewed at https://www.dailypolitical.com/2017/08/13/cvs-health-corporation-nysecvs-shares-bought-by-mitchell-mcleod-pugh-williams-inc.html.

Several analysts recently commented on the company. Vetr lowered CVS Health Corporation from a “buy” rating to a “hold” rating and set a $85.78 price objective for the company. in a report on Thursday, April 27th. Cowen and Company reaffirmed an “outperform” rating and issued a $86.00 price objective on shares of CVS Health Corporation in a report on Tuesday, June 13th. BidaskClub raised CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 2nd. Leerink Swann set a $90.00 price target on CVS Health Corporation and gave the company a “buy” rating in a report on Tuesday, June 27th. Finally, Needham & Company LLC started coverage on CVS Health Corporation in a report on Tuesday, June 27th. They set a “hold” rating for the company. Eight research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $91.27.

In other news, CFO David M. Denton sold 230,510 shares of the firm’s stock in a transaction dated Monday, June 12th. The stock was sold at an average price of $80.00, for a total transaction of $18,440,800.00. Following the sale, the chief financial officer now directly owns 176,983 shares in the company, valued at approximately $14,158,640. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Helena Foulkes sold 20,333 shares of the firm’s stock in a transaction dated Monday, June 26th. The shares were sold at an average price of $80.00, for a total value of $1,626,640.00. Following the sale, the executive vice president now owns 59,301 shares in the company, valued at $4,744,080. The disclosure for this sale can be found here. Insiders have sold a total of 271,175 shares of company stock worth $21,632,597 over the last 90 days. Insiders own 0.61% of the company’s stock.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health Corporation (NYSE:CVS)

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.